Insider Transactions in Q4 2022 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2022
|
Patrick J Mcenany Director |
SELL
Bona fide gift
|
Direct |
10,000
-0.26%
|
-
|
|
Dec 28
2022
|
Patrick J Mcenany Director |
SELL
Bona fide gift
|
Direct |
10,000
-0.26%
|
-
|
|
Dec 06
2022
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+0.43%
|
-
|
|
Dec 06
2022
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+0.24%
|
-
|
|
Dec 06
2022
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+3.37%
|
-
|
|
Dec 06
2022
|
Patrick J Mcenany Director |
SELL
Payment of exercise price or tax liability
|
Direct |
12,133
-0.31%
|
-
|
|
Dec 06
2022
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,834
+0.78%
|
-
|
|
Dec 06
2022
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
5,918
-16.12%
|
$94,688
$16.85 P/Share
|
|
Dec 06
2022
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,667
+28.54%
|
-
|
|
Dec 06
2022
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,667
+25.83%
|
-
|
|
Dec 06
2022
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,667
+10.09%
|
-
|
|
Dec 06
2022
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+0.48%
|
-
|
|
Dec 06
2022
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+1.4%
|
-
|
|
Dec 06
2022
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+0.88%
|
-
|
|
Nov 23
2022
|
Philip H Coelho Director |
SELL
Open market or private sale
|
Direct |
9,999
-6.27%
|
$169,983
$17.45 P/Share
|
|
Nov 23
2022
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-3.49%
|
$340,000
$17.34 P/Share
|
|
Nov 22
2022
|
Philip H Coelho Director |
SELL
Open market or private sale
|
Direct |
20,001
-11.14%
|
$340,017
$17.3 P/Share
|
|
Nov 22
2022
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
120,000
-81.39%
|
$1,920,000
$16.53 P/Share
|
|
Nov 21
2022
|
Philip H Coelho Director |
SELL
Open market or private sale
|
Direct |
70,000
-28.05%
|
$1,050,000
$15.23 P/Share
|
|
Nov 21
2022
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
80,000
-12.24%
|
$1,200,000
$15.28 P/Share
|
|
Nov 21
2022
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
150,000
-3.7%
|
$2,250,000
$15.33 P/Share
|
|
Nov 21
2022
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+3.57%
|
$300,000
$2.24 P/Share
|
|
Nov 18
2022
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
350,000
-8.23%
|
$5,250,000
$15.62 P/Share
|
|
Nov 18
2022
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
350,000
+7.6%
|
$700,000
$2.24 P/Share
|
|
Nov 15
2022
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
60,000
-28.92%
|
$900,000
$15.77 P/Share
|
|
Nov 15
2022
|
Charles B O'Keeffe Director |
BUY
Open market or private sale
|
Direct |
87,985
+13.47%
|
$1,407,760
$16.04 P/Share
|
|
Nov 14
2022
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
105,000
+35.85%
|
$105,000
$1.32 P/Share
|
|
Nov 11
2022
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
139,017
-100.0%
|
$2,085,255
$15.85 P/Share
|
|
Nov 11
2022
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
139,017
+50.0%
|
$278,034
$2.55 P/Share
|
|
Nov 11
2022
|
Donald A Denkhaus Director |
SELL
Open market or private sale
|
Direct |
20,000
-6.72%
|
$320,000
$16.59 P/Share
|
|
Nov 11
2022
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Open market or private sale
|
Direct |
14,666
-56.93%
|
$234,656
$16.23 P/Share
|
|
Nov 11
2022
|
Preethi Sundaram Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
56,786
-75.0%
|
$908,576
$16.38 P/Share
|
|
Nov 11
2022
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,786
+50.0%
|
$283,930
$5.49 P/Share
|